Saurabh Singh, Shonit Punwani, David G Gadian, Alan Bainbridge, Xavier Golay, Aaron Oliver-Taylor, Jung Ryu, Lucy Caselton, Adam Retter, Rafat Chowdhury, Tom Syer, Manju Mathew, Harriet Rogers, Max Bullock, Fiona Gong, Lorna Smith, Christoph A Müller, Marianthi-Vasiliki Papoutsaki
Journal: The British journal of radiology 2022;95(1134):20210770
PMID: 35230136
OBJECTIVE
To develop a phantom system which can be integrated with an automated injection system, eliminating the experimental variability that arises with manual injection; for the purposes of pulse sequence testing and metric derivation in hyperpolarised C-MR.
METHODS
The custom dynamic phantom was machined from Ultem and filled with a nicotinamide adenine dinucleotide and lactate dehydrogenase mixture dissolved in phosphate buffered saline. Hyperpolarised [1-C]-pyruvate was then injected into the phantom ( = 8) via an automated syringe pump and the conversion of pyruvate to lactate monitored through a C imaging sequence.
RESULTS
The phantom showed low coefficient of variation for the lactate to pyruvate peak signal heights (11.6%) and dynamic area-under curve ratios (11.0%). The variance for the lactate dehydrogenase enzyme rate constant (kP) was also seen to be low at 15.6%.
CONCLUSION
The dynamic phantom demonstrates high reproducibility for quantification of C-hyperpolarised MR-derived metrics. Establishing such a phantom is needed to facilitate development of hyperpolarsed C-MR pulse sequenced; and moreover, to enable multisite hyperpolarised C-MR clinical trials where assessment of metric variability across sites is critical.
ADVANCES IN KNOWLEDGE
The dynamic phantom developed during the course of this study will be a useful tool in testing new pulse sequences and standardisation in future hyperpolarised work.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.